1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study
    Meeting Abstract

    Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Savage, K. J.; Smolewski, P.; Bartlett, N. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrent glioblastoma (GBM)
    Meeting Abstract

    Strowd, R. E.; Ellingson, B. M.; Wen, P. Y.; Ahluwalia, M. S.; Piotrowski, A. F.; Desai, A. S.; Clarke, J. L.; Lieberman, F. S.; Desideri, S.; Nabors, L. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Crenolanib versus midostaurin combined with induction and consolidation chemotherapy in newly diagnosed FLT3 mutated AML
    Meeting Abstract

    Stone, R. M.; Wang, E. S.; Goldberg, A. D.; Sweet, K. L.; Fathi, A. T.; Liu, H.; Messahel, B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Inclusion of patient-reported outcomes (PROs) in randomized controlled trials (RCTs) with elderly cancer patients: A systematic review
    Meeting Abstract

    Sparano, F.; Aaronson, N. K.; Sprangers, M. A. G.; Fayers, P.; Pusic, A.; Kieffer, J. M.; Rees, J.; Wan, C.; Pezold, M.; Fuzesi, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Does the quality of patient-reported outcomes (PROs) assessment in randomized controlled trials (RCTs) differ across cancer types and overtime? A pooled analysis of 610 RCTs published between 2004 and 2018
    Meeting Abstract

    Sparano, F.; Aaronson, N. K.; Sprangers, M. A. G.; Fayers, P.; Pusic, A.; Kieffer, J. M.; Rees, J.; Wan, C. H.; Pezold, M.; Fuzesi, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Burden of thrombocytopenia in adult cancer patients receiving chemotherapy
    Meeting Abstract

    Soff, G. A.; Shaw, J.; Kilpatrick, K.; Marongiu, A.; Park, J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors
    Meeting Abstract

    Sonpavde, G.; Manitz, J.; Gao, C.; Hennessy, D.; Makari, D.; Niegisch, G.; Rosenberg, J. E.; Bajorin, D. F.; Grivas, P.; Apolo, A. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of convection-enhanced delivery of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma: An update with dose-response assessment
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zhou, Z.; Zanzonico, P.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502)
    Meeting Abstract

    Sinicrope, F. A.; Ou, F. S.; Zemla, T.; Nixon, A. B.; Mody, K.; Levasseur, A.; Dueck, A. C.; Dhanarajan, A. R.; Lieu, C. H.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV plus NPC)
    Meeting Abstract

    Siu, L. L.; Bauml, J.; Adkins, D.; Colevas, A. D.; Perez, C. A.; Choe, J. H.; Zhang, Y.; Shi, W.; Navarro, W. H.; Haigentz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save